News

Revolutionary Heart Stent for Infants at Nicklaus Children's

Revolutionary Heart Stent for Infants at Nicklaus Children's

Revolutionary Heart Stent for Infants at Nicklaus Children's

New FDA-approved Minima Stent grows with a child's heart, preventing the need for open heart surgeries

Nicklaus Children's Hospital's Heart Institute is making waves in pediatric cardiac care with the introduction of the Minima Stent, an innovative device created specifically for infants and young children. This groundbreaking technology, approved by the FDA, is a first of its kind that expands in size as a child's heart develops, providing hope for families facing congenital heart disease.

Transformative Advances in Pediatric Cardiology

The Minima Stent is engineered to address the unique complexities of a child's cardiovascular system. Unlike standard stents used primarily in adults, which come with limitations in expansion, the Minima Stent can be gradually dilated as the child grows. This important feature diminishes the likelihood of needing multiple surgeries, allowing children to lead healthier lives without the burden of frequent medical interventions.

Expert Insights on the Minima Stent

Dr. Sathanandam, the chief of cardiovascular medicine at Nicklaus Children’s Heart Institute, emphasizes the significance of this advancement. He stated, "This is an exciting milestone for the children and families navigating the treacherous journey of congenital heart disease. The Minima Stent fills a critical void in pediatric care, providing a safe, expandable device that aligns perfectly with the needs of growing children." His partnership with leaders from Renata Medical facilitated this remarkable innovation, which he believes will reshape pediatric cardiology.

Built for Adaptability and Hope

The Minima Stent is specifically designed for placement in small blood vessels. It uniquely provides a solution that can grow alongside the patient as they mature, eventually adapting to adult sizes. This flexibility is a beacon of hope for many young patients, pointing towards a future where complex heart surgeries may not be necessary. Dr. Daniel Duarte Caceres, the medical director of interventional cardiology at Nicklaus Children's, shares his thoughts: "Traditionally, we had to rely on adult-sized stents, which posed numerous challenges for children. The Minima Stent stands as a revolutionary tool that caters to the delicate needs of our youngest patients, diminishing the need for repetitive procedures throughout their growth."

Nicklaus Children's Heart Institute: A Leader in Care

Renowned globally for its professional excellence, the Nicklaus Children's Heart Institute treats thousands of children each year, offering comprehensive care for both congenital and acquired heart conditions. The institute is committed to utilizing cutting-edge technologies to provide patients with alternatives to open-heart surgeries, reflecting a continuous dedication to innovative approaches in medicine.

Pediatric Catheterization Program: Setting New Standards

The institute's Pediatric and Congenital Catheterization Program has earned recognition as one of the foremost leaders in the field. It embraces the use of advanced imaging and device technologies, enabling doctors to conduct both simple and complex interventions. This innovative mindset is critical in either minimizing or completely removing the necessity for surgical options like open-heart surgery, showcasing the hospital's commitment to improving pediatric healthcare outcomes.

To learn more about Nicklaus Children's Heart Institute and its services, please visit their official website.

About Nicklaus Children's Hospital

Nicklaus Children's Hospital stands as South Florida's leading nonprofit, specialty licensed hospital dedicated exclusively to caring for children. With a vast network of more than 850 physicians, of which over 500 are pediatric subspecialists, the hospital serves an impressive portion of the region's children. It boasts advanced facilities, including the Kenneth C. Griffin Surgical Tower and multiple centers of excellence, offering specialized care across various medical fields. Nicklaus Children’s is honored to provide a haven for pediatric treatments and has continuously ranked among the best nationwide.

Contact Information

Alejandra Sanchez, PR Specialist
Nicklaus Children's Health System
Contact: [contact information]

Frequently Asked Questions

What is the Minima Stent?

The Minima Stent is an FDA-approved heart stent designed for infants that expands as a child's heart grows, reducing the need for repeated surgeries.

How does the Minima Stent benefit children?

This stent allows for safer cardiac treatment by adapting to the child's growth, helping them avoid invasive surgical procedures as they develop.

Who developed the Minima Stent?

The Minima Stent was developed in collaboration between experts at Nicklaus Children's Heart Institute and leaders from Renata Medical.

Why is this stent a breakthrough in pediatric cardiology?

It is purpose-built for young patients, unlike traditional stents, radically changing the approach in treating congenital heart defects in children.

Can the stent be used in both small and adult-sized blood vessels?

Yes, the Minima Stent is designed to expand from small blood vessels to sizes suitable for adults over time, ensuring a long-term solution.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 144

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 727

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 331

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading